| pubmed-article:18316955 | pubmed:abstractText | The lack of a strong evidence base in primary prevention, concerns for adverse effects, and inability to risk stratify elderly patients have led to underprescribing of statins in elderly patients. Our review will focus on statins in primary prevention, newer assessment tools for risk stratification, and statin safety. | lld:pubmed |
